Dyslipidemia in children with chronic kidney disease

Jeffrey M Saland1, Christopher B Pierce, Mark M Mitsnefes

  • 1Department of Pediatrics, The Mount Sinai School of Medicine, New York, New York 10029, USA. Jeff.Saland@mssm.edu

Kidney International
|August 26, 2010
PubMed

Insights

Dyslipidemia is common in children with chronic kidney disease (CKD). Lower kidney function and proteinuria significantly increase the risk of dyslipidemia in pediatric CKD patients.

Area of Science:

  • Pediatric Nephrology
  • Cardiovascular Risk Factors
  • Chronic Kidney Disease

Background:

  • Dyslipidemia is a significant risk factor for atherosclerosis.
  • It is frequently observed in both adult and pediatric populations with chronic kidney disease (CKD).

Purpose of the Study:

  • To determine the prevalence and patterns of dyslipidemia in children with CKD.
  • To identify associations between dyslipidemia and clinical factors in pediatric CKD.

Main Methods:

  • Cross-sectional analysis of 391 children (aged 1-16 years) from the CKiD study.
  • Glomerular filtration rate (GFR) measured by iohexol clearance.
  • Multivariate analysis adjusted for age, gender, BMI, GFR, and urinary protein/creatinine ratio.

Main Results:

  • High prevalence of hypertriglyceridemia (126/391), increased non-HDL-C (62/391), and reduced HDL-C (83/391) were observed.
  • 177 children (45%) had dyslipidemia, with 79 (20%) having combined dyslipidemia.
  • Lower GFR and nephrotic-range proteinuria were significantly associated with increased odds of dyslipidemia.

Conclusions:

  • Dyslipidemia is highly prevalent in children with moderate CKD.
  • Lower GFR and nephrotic proteinuria are key risk factors for dyslipidemia in this population.
  • Non-renal factors like age and obesity also contribute to dyslipidemia in pediatric CKD.

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...